CHOP Cancer Researchers Win 2021 AACR Team Science Award
Published on
The award was presented to the St. Baldrick’s Foundation-Stand Up 2 Cancer Pediatric Cancer Dream Team, co-led by CHOP, at the annual AACR conference.
Solid Tumor Program News and Updates
1 - 10 of 31
CHOP Researchers Awarded Crazy 8 Grant from Alex’s Lemonade Stand Foundation
Published on
CHOP researchers will receive funds to discover a new drug that targets MYCN, a transcription factor involved in some pediatric cancers.
Yael Mossé, MD, Featured by the Conquer Cancer Foundation
Published on
The CHOP physician-researcher’s investigation into cause of and treatment for neuroblastoma has been supported by Conquer Cancer grants.
Case Study: Osteosarcoma and Limb Salvage Surgery
Published on
Read this case study about a patient who received treatment for osterosarcoma and underwent limb salvage surgery at Children’s Hospital of Philadelphia.
New Treatment Shows Success in High-Risk Solid Tumors
Published on
The CHOP-engineered therapy overcomes common drug resistance and has potential to elicit fewer toxicities than most cancer treatments.
Case Study: The Benefits of Vascularized Fibular Graft After Bone Tumor Resection
Published on
This case study highlights a multimodal approach to surgical management of osteosarcomas in young children, maximizing control while providing a functional limb that will grow with the child.
CHOP Welcomes World-Renowned Sarcoma Expert
Published on
Patrick J. Grohar, MD, PhD, focuses on developing therapies for a cancer that’s rare in adults but relatively common in the pediatric population.
Researchers Working Hard to Find a Cure for Ewing’s Sarcoma
Published on
An unrelenting, deep bone pain that woke him up from sleep is what led to Jake’s diagnosis just last March of Ewing sarcoma, one of the most common bone tumors in children and adolescents.
Children’s Hospital of Philadelphia Announces Endowed Chair in Pediatric Neuroblastoma Research
Published on
CHOP recipient, physician-scientist Dr. Yael Mossé, is innovating targeted, less toxic therapies for cancer affecting mostly infants and young children.
CHOP Pioneers Helped Ensure Drug Is Available to Children
Published on
CHOP physician-scientists applaud a new drug for childhood cancer that targets a key genetic driver of cancer rather than a specific type of tumor.